J., Bickel, C., Torzewski, M., Hafner, G., Tiret, L., & Lackner, K
[5] [6] Some agents in this class (including liraglutide, semaglutide and dulaglutide) have demonstrated cardiovascular benefits in clinical trials, though specific benefits vary by individual medication
10.1016/j.neulet.2014.03.056 Neurosci
The patient told medical staff at the emergency department that he typically had good blood sugar control using an insulin pump, but he arrived at the hospital with a blood glucose reading over 300 mg/dl
Most GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) do not require dose adjustment in renal impairment, though exenatide should be avoided if eGFR is below 30 mL/min/1.73m